Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Nottingham Hospitals University Trust, Nottingham, UK.
Dig Dis. 2023;41(6):900-912. doi: 10.1159/000533946. Epub 2023 Sep 13.
The etiology of liver diseases has changed significantly, but its impact on the comparative burden of cirrhosis between males and females is unclear. We estimated sex differences in the burden of cirrhosis across 204 countries and territories from 2010 to 2019.
We analyzed temporal trends in the burden of cirrhosis using the methodology framework of the 2019 Global Burden of Disease study. We estimated annual frequencies and age-standardized rates (ASRs) of cirrhosis incidence, death, and disability-adjusted life-years (DALYs) by sex, region, country, and etiology.
In 2019, the frequency of incident cases, deaths, and DALYs due to cirrhosis was 1,206,125, 969,068, and 31,781,079 in males versus 845,429, 502,944, and 14,408,336 in females, respectively. From 2010 to 2019, the frequency of cirrhosis deaths increased by 9% in males and 12% in females. Incidence ASRs remained stable in males but increased in females, while death ASRs declined in both. Death ASRs for both sexes declined in all regions, except in the Americas where they remained stable. In 2019, alcohol was the leading cause of cirrhosis deaths in males, and hepatitis C in females. Death ASRs declined for all etiologies in both sexes, except in nonalcoholic steatohepatitis (NASH). The ratio of female-to-male incidence ASRs in 2019 was lowest in alcohol(0.5), and highest in NASH(1.3), while the ratio of female-to-male death ASRs was lowest in alcohol(0.3) and highest in NASH(0.8).
The global burden of cirrhosis is higher in males. However, incidence and death ASRs from NASH cirrhosis in females are comparable to that of males.
肝脏疾病的病因已发生显著变化,但尚不清楚其对男性和女性肝硬化负担的影响。我们评估了 2010 年至 2019 年期间 204 个国家和地区肝硬化负担的性别差异。
我们使用 2019 年全球疾病负担研究的方法框架分析了肝硬化负担的时间趋势。我们按性别、地区、国家和病因估计了肝硬化发病率、死亡率和伤残调整生命年(DALY)的年频率和年龄标准化率(ASR)。
2019 年,男性肝硬化新发病例、死亡和 DALY 频率分别为 1,206,125、969,068 和 31,781,079,女性分别为 845,429、502,944 和 14,408,336。2010 年至 2019 年,男性肝硬化死亡频率增加了 9%,女性增加了 12%。男性肝硬化发病率 ASR 保持稳定,女性则增加,而死亡率 ASR 则下降。除美洲地区保持稳定外,所有地区的男女死亡率 ASR 均下降。2019 年,男性肝硬化死亡的主要原因为酒精,女性则为丙型肝炎。除非酒精性脂肪性肝炎(NASH)外,所有病因的男女死亡率 ASR 均下降。2019 年,女性肝硬化发病率 ASR 与男性之比最低的为酒精(0.5),最高的为 NASH(1.3),而女性肝硬化死亡率 ASR 与男性之比最低的为酒精(0.3),最高的为 NASH(0.8)。
全球肝硬化负担在男性中更高。然而,女性 NASH 肝硬化的发病率和死亡率 ASR 与男性相当。